Answers are grounded in this paper and cite their sources.
Public mouse brain single-cell and single-nucleus RNA sequencing (sc/snRNA-seq) datasets are difficult to reuse across studies because sample annotations are heterogeneous and incomplete. We harmonized sample-level metadata for 2,005 cortex and hippocampus samples from 389 studies, covering wild-type (WT) controls and Alzheimer's disease (AD)-related mouse models. Usable count data from 1,863 samples in 360 studies were uniformly processed into 12,628,942 cell and nuclear profiles with cell-type annotations. Expression-based indicators were consistent with the annotated sequencing protocol and sex, and integrated microglial profiles recovered established AD-associated signatures. To illustrate cross-study use, we asked whether microglial AD--WT expression differences varied with age and between cortex and hippocampus, using covariate-adjusted expression reconstructed with Kanade. Genes separated into groups with predominantly negative or positive AD--WT contrasts, including a group whose age-associated contrasts differed between cortex and hippocampus. These findings demonstrate the utility of harmonized metadata for investigating age- and region-dependent AD-associated transcriptional differences across studies. The resource supports explicit, reproducible cohort definitions across public mouse brain datasets.
No takes yet. Share an insight, caveat, or question.
Ijiri et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: